Silver Book Fact

Greater use of clot-busting drug t-PA in ischemic
stroke patients could save the health care system
over $100 million a year.

New Stroke Treatment Likely to Decrease Health Care Costs and Increase Quality of Life. http://www.ninds.nih.gov/news_and_events/press_releases/pressrelease_stroke_treatment_042298.htm. Published 21-Apr-1998

Reference

Title
New Stroke Treatment Likely to Decrease Health Care Costs and Increase Quality of Life
Publication Date
Published 21-Apr-1998
Authors
National Institutes of Health, National Institute of Neurological Disorders and Stroke
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Cost-savings associated with Warfarin use in AFib patients
    Warfarin use in Medicare patients with nonvalvular atrial fibrillation was independently associated with lower medical costs averaging $9,836 per patient, per year.  
  • Disease specific status and generic health status improvements from TAVR and SAVR
    Transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in intermediate risk symptomatic aortic stenosis (SAS) patients were associated with significant improvements in disease specific status (16 to…  
  • “Coronary heart disease spending has increased more than 40% over the past 15 years, and, as a whole, the health improvements have been well worth the costs. Over the entire…  
  • Surgical Aortic Valve Replacements in 2010
    In 2010, ~67,500 surgical aortic valve replacements (SAVR) were performed in the U.S.  
  • It is estimated that the number of quality-adjusted life-years achieved with each $1 million spent on antihypertensive drug therapy is between 20-50 to more than 200.